Browsing Tag
Marcus Schindler
3 posts
Novo Nordisk and Valo Health expand AI partnership to tackle cardiometabolic diseases
Novo Nordisk and Valo Health have strengthened their collaboration to advance AI-driven drug discovery, targeting major cardiometabolic diseases,…
Novo Nordisk signs $3.3bn deal to acquire Dicerna Pharmaceuticals
Novo Nordisk has signed a deal worth around $3.3 billion to acquire Dicerna Pharmaceuticals, a US-based biotech company…
Novo Nordisk acquires Ziylo in $800m deal to advance diabetes treatment
Novo Nordisk, a leading Danish pharmaceutical company, has completed a significant acquisition of Ziylo, a biotechnology spin-out from…